Newcastle disease virus (NDV)-attenuated vaccine has been widely used to prevent ND in poultry flocks, while many reports also mentioned the exogenous virus contamination in attenuated vaccines, which might be the reason for the widespread of some contagious diseases. Recently, the chicken infectious anemia virus (CIAV) contamination in the NDVattenuated vaccine was also found in China, though no systemic study has studied the pathogenicity or infection mechanism of this special transmission route. Accordingly, simulation experiments were launched using CIAV isolated from a contaminated NDV-attenuated vaccine. Results showed that using NDV-attenuated vaccine contaminated with CIAV could cause CIA in chickens with obvious symptoms, including anemia, hemorrhage, lymphoatrophy, and growth retardation, while the synergistic reaction of CIAV and LaSota prompted their multiplication in vivo and disturbed the production of antibodies against each other. And CIAV could significantly reduce the NDV antibody titers and decrease the protective effectiveness. This study showed the synergetic pathogenicity of CIAV and LaSota strain after using contaminated NDV-attenuated vaccine, helping us to understand how the CIAV causes infection and induces severe diseases with a relatively low dose through the mouth, as well as reminding us that the damage of an attenuated vaccine contaminated with CIAV even in extremely low dose is not insignificant.
INTRODUCTION
The World Organization for Animal Health has defined Newcastle disease (ND) as the infection of poultry with virulent strains of Newcastle disease virus (NDV). Lesions affecting the neurological, gastrointestinal, respiratory, and reproductive systems are most often observed (Ganar et al., 2014; Brown and Bevins, 2017) . The control of ND must include strict biosecurity that prevents virulent NDV from contacting poultry, as well as proper administration of efficacious vaccines. When administered correctly to healthy birds, ND vaccines formulated with NDV of low virulence or viral-vectored vaccines that express the NDV fusion protein are able to prevent clinical disease and mortality in chickens upon infection with virulent NDV. Live vaccines have been widely used since the 1950s and made great progress in C 2018 Poultry Science Association Inc. Received March 16, 2018 . Accepted November 21, 2018 Corresponding author: zhaopeng@sdau.edu.cn preventing and controlling ND (Dimitrov et al., 2017) . However, many reports mentioned the exogenous virus contamination in attenuated vaccines, and the CIAV contamination was also found in the NDV-attenuated vaccine (Li et al., 2017b) .
Chicken infectious anemia, caused by chicken infectious anemia virus (CIAV), is an extremely epidemic immunosuppressive disease causing the atrophy of bone marrow, hematopoietic tissue, and lymphatic tissues (e.g., thymus) in young chickens, leading to anemia and immune suppression (Hoop, 1992; Miller and Schat, 2004) . After its first report in 1979 (Yuasa et al., 1979) , CIAV has been detected worldwide and has caused huge economic losses (Rosenberger and Cloud, 1989; Zhou et al., 1996; Ducatez et al., 2006; Natesan et al., 2006; Craig et al., 2009; Kim et al., 2010; Smuts, 2014; Gholami-Ahangaran, 2015; Ganar et al., 2017) . Recently, CIAV infections have also frequently appeared in different chicken flocks in China (Zhang et al., 2013; Fang et al., 2017; Li et al., 2017a) .
CIAV can be spread both vertically and horizontally, while the use of attenuated vaccine contaminated with 1985 CIAV was suspected as an important transmission route (Yuasa et al., 1979; Marin et al., 2013; Varela et al., 2014) . Although the interaction of CIAV and NDVattenuated vaccine had been studied in the past (Box et al., 1988; De Boer et al., 1994; Lebdah et al., 2016) , the contaminated dose of exogenous virus in vaccine was extremely low in common cases, which was usually considered to be non-pathogenic especially under the oral vaccination. Therefore, in this study, systemic animal experiments were launched to observe the synergetic pathogenicity of CIAV and LaSota strain after using contaminated NDV-attenuated vaccine.
METHODS AND MATERIALS

Ethics Statement
The animal care and use protocol was approved by the Shandong Agricultural University Animal care and use Committee (SDAUA-2016-002) . All of the experimental animals of this study were cared for and maintained throughout of the experiments strictly following the ethics and biosecurity guidelines approved by the Institutional Animal Care and Use Committee of Shandong Agricultural University.
Vaccine Backgroud
In the second half of 2015, extremely high positive rate of CIAV infection appeared suddenly on a large-scale poultry farm with obvious clinical symptoms, including anemia and generalized lymphoatrophy. The possibility of horizontal transmission was very small with a reliable external quarantine standard and no exotic chickens. To ensure the association between the disease and vaccine contamination, corresponding real-time fluorescence quantitative polymerase chain reactions (qPCR) were launched for the detection of avian leukosis virus (ALV), reticuloendotheliosis virus (REV), fowl adenovirus (FAdV), and CIAV in the attenuated vaccines from this farm (Günes et al., 2012; Dai et al., 2015; Luan et al., 2016; Ren et al., 2016) . Surprisingly, the results showed the contamination of CIAV, named as CIAV-N22 (Genbank accession number: KU845734), in the NDV-attenuated vaccine (Li et al., 2017b) . Thus, we speculated that using such contaminated vaccine might be an important reason for the outbreak of CIA in above-mentioned poultry farm.
Isolation and Quantification of CIAV
According to a previous report , 1 mL of vaccine seed was mixed well with 1 mL of NDVspecific serum (prepared by the China Institute of Veterinary Drug Control), and the mixtures were shaken and incubated at 37
• C for 60 min for neutralization and filtered through a 0.22-μm filter. The filtered solution was used to inoculate 7-day-old SPF chicken embryos and then allantoic fluid was gathered around 4 to 6 d post infection. After repeated neutralization, the isolate of CIAV was detected by qPCR for the existence of NDV (Jiang et al., 2011) . The titer of this CIAV isolate was measured by egg inoculation using the ReedMuench method (Reed and Muench, 1938) and is presented as the EID 50 /0.1 mL.
Animal Experimental Design
One-day-old SPF chickens (SPAFAS poultry company, Jinan, China) were wing banded and randomly divided into 6 groups. Each group had 15 chickens, which were separately reared in shielded cages with positive filtered air. Using CIAV-N22 isolate, different contaminated vaccines were artificially prepared as trial samples to vaccinate chicks orally at 7 d age. Specifically, NDV-attenuated vaccine purchased from local veterinary vaccine market (all negative in above-mentioned pathogens test) was diluted with normal saline according to the instructions, and the final volume of each plume was around 200 μl. Afterwards, CIAV-N22 was diluted with normal saline to 50 EID 50 /μL as well as 10 EID 50 /μL and then added into each plume of diluted vaccine. Meanwhile, CIAV-N22 in same doses was also diluted with phosphate-buffered saline (PBS) for the same operation. Specific groups and treatments are shown in Table 1 .
Measurement of Body Weight and Immune Organs Indices
To compare the effects of viral infection on growth retardation and immunosuppression, the growth and death of the chicks were measured daily. The weight of each chick in the 7 groups was measured at weeks 1, 2, 3, 4, 5, and 6 of the experiment. At 3 wk of age, 3 chicks of each group were randomly chosen and euthanized, and the tissues were collected including the thymus, spleen, and bursa of Fabricius and preserved at -80
• C. At 6 wk of age, samples of thymus, spleen, and bursa of Fabricius were excised from all chicks and weighed. After weighing the organs, the immune organ indices of the thymus, spleen, and bursa of Fabricius were calculated as organ weight (wet weight, mg)/BW (g) × 100%. Clinical symptoms in bursa of liver, thymus, Fabricius, and leg muscles, thymus, and obvious red blood cells' infiltration in those tissues (E-H). The hemorrhage and red blood cells infiltration were marked with black arrows. H&E stain, ×400, the scale bar = 50 μm.
Quantification of Viral Load
The tissues of the same 3 chicks chose and euthanized for measuring immune organ indices at 3 wk of age were also collected including the lung, terminal trachea, heart, liver, thymus, spleen, and bursa of Fabricius for RNA extraction (Omega Bio-Tek, Norcross, GA) to measure the LaSota viral load in different organs according to the previous published methods (Jiang et al., 2011) . Meanwhile, genome DNA was also extracted from those organs by DNA extraction kit (Omega Bio-Tek) for the quantification of CIAV viral load using published qPCR methods (Ren et al., 2016) . On the other hand, anticoagulant blood from all chickens was collected with heparin sodium at days 10, 14, 21, 28, and 35 of the experiment for DNA extraction to determine the viremia level of CIAV. The qPCR reactions were set up on ice, and an ABI PRISMR 7500 Sequence Detection System (Applied Biosystems) was used to amplify and detect the reaction products. The qPCR was performed in duplicate, with each sample present in technical duplicate during each run. In addition, a separate set of samples from each tissue was fixed in 10% neutral-buffered formalin and embedded in paraffin wax, and then cut into 4 μm thick sections, which were stained with hematoxylin and eosin for microscopic examination.
Antibody Responses to NDV and CIAV
Sera from all chickens were collected at weeks 2, 3, 4, 5, and 6 of the experiment for hemagglutination inhibition testing to determine the concentrations of NDV antibodies in accordance with the routine procedures (Soleimani et al., 2018) , while the CIAV antibody level of those samples was also determined using the CIAV antibody test kit (Zoetis) according to the instructions.
Statistical Analysis
Statistical analysis was performed using the SPSS statistical software package for Windows version 17.0 (SPSS Inc. Chicago, IL). P < 0.05 was considered statistically significant based on Duncan's multiple-range test.
RESULTS
CIAV Vaccine Strain was Isolated Successfully
After repeated serum neutralizations, chick embryo inoculation, and separation, CIAV-N22 isolate was successfully isolated from the contaminated NDVattenuated vaccine. Detected by qPCR, the CIAV vaccine strain was determined to be purified without ALV, REV, FAdV, and NDV. The titer of this CIAV isolate was determined to be 10 4.2 EID 50 /0.1 mL.
Clinical Symptoms
During the experiments, no chick died after administrating PBS or the attenuated NDV vaccine without contamination or vaccines that contained CIAV, which indicated that the NDV vaccine contaminated with a low dose of CIAV did not cause death. But clinical symptoms including hemorrhage in liver ( Figure 1A ), thymus ( Figure 1B) , bursa of Fabricius ( Figure 1C) , and leg muscle ( Figure 1D ) appeared in chicks of groups LaSota/CIAV/HD and LaSota/CIAV/LD rather than group PBS/CIAV/HD or PBS/CIAV/LD. And, histological lesions also showed similar results that massive red blood cell infiltration was observed in those tissues ( Figures 1E-1H ). All these results demonstrated that using NDV-attenuated vaccine contaminated with CIAV could cause CIA in chickens. 
Body Weights
As shown in Table 2 , no significant difference was observed between the group PBS and group LaSota (P > 0.05), which demonstrated that normal vaccination has low impact on the weight growth of SPF chickens. But the body weights of chickens in group PBS and group LaSota were significantly increased as compared to that of other groups (P < 0.05) at different day ages. More importantly, the body weights of chickens in group LaSota/CIAV/HD and group LaSota/CIAV/LD were apparently lower than that of group PBS/CIAV/HD and group PBS/CIAV/LD (P < 0.05), which illustrated that the interaction of CIAV and LaSota aggravated the growth retardation SPF chickens.
Immune Organs Indices
As shown in Table 3 , chickens in group LaSota exhibited slight atrophy in thymus, spleen, and bursa of Fabricius as compared to that of the chickens from group PBS (P > 0.05), which demonstrated that LaSota could also disturb the development of immune organs mildly in normal vaccination. The organs of the immune system of other groups showed different degrees of lesion, including splenomegaly and atrophy of the thymus gland, while the injuries in group LaSota/CIAV/HD and group LaSota/CIAV/LD were significantly higher than that of group PBS/CIAV/HD and group PBS/CIAV/LD (P < 0.05), which showed that the interaction of CIAV and LaSota aggravated each other's capacity for destruction of immune system. On the other hand, comparing with other groups, the bursa of Fabricius in group PBS/CIAV/HD and group PBS/CIAV/LD showed different degrees of swelling (P < 0.05).
CIAV Contamination Elevates the LaSota Viral load in Different Organs
At 3 wk of age, samples of the lung, terminal trachea, heart, liver, thymus, spleen, and bursa of Fabricius were excised from 3 chicks randomly chosen from each group for RNA extraction to mensurate the LaSota viral load in different organs. Results showed that the LaSota viral loads in lung, terminal trachea, heart, liver, thymus, spleen, and bursa of Fabricius of group LaSota/CIAV/HD and group LaSota/CIAV/LD were significantly higher than that of group LaSota (P < 0.05), which demonstrated that CIAV contamination could elevate the LaSota viral load in different organs (Figure 2) . At the same time, the more CIAV contamination dose is the higher improvement of LaSota viral load in lung, terminal trachea, and bursa of Fabricius shown in this experiment.
LaSota Elevates the CIAV Viral Load in Spleen, Liver and Thymus
At 3 wk of age, samples of the lung, terminal trachea, heart, liver, thymus, spleen, and bursa of Figure 2 . LaSota viral loads in different organs. Different organs were excised from 3 chicks randomly chosen from each group at 3 wk of age to determine the LaSota viral load, which was represented as Log copies/μL (mean value ± error). The NDV viral load value of contaminated group was compared with that of the corresponding noncontaminated group ( * P < 0.05) based on Duncan's multiple-range test. Figure 3 . CIAV viral loads in different organs Different organs were excised from 3 chicks randomly chosen from each group at 3 wk of age to determine the CIAV viral load, which was represented as Log copies/μL (mean value ± error). The CIAV viral load value of vaccination group was compared with that of the corresponding nonvaccination group ( * P < 0.05) based on Duncan's multiple-range test.
Fabricius were excised from 3 chicks randomly chosen from each group for DNA extraction to mensurate the CIAV viral load in different organs. Results showed that there is a great deal of CIAV in lung, liver, spleen, and thymus, while the CIAV viral loads of heart and bursa of Fabricius were extremely low. The CIAV viral loads in spleen, liver, and thymus of group LaSota/CIAV/HD and group LaSota/CIAV/LD were significantly higher than that of group PBS/CIAV/HD and group PBS/CIAV/LD (P < 0.05, Figure 3 ). In addition, the CIAV viral load in terminal trachea was too low to detect.
LaSota Elevates the CIAV viremia Level in Early Infection
CIAV viremia levels were compared between group LaSota/CIAV/HD and group PBS/CIAV/HD ( Figure 4A ) or LaSota/CIAV/LD and group PBS/CIAV/LD ( Figure 4B ) at 10 d, and 2, 3, 4, and 5 wk post hatched. Results showed that the CIAV viremia levels of LaSota/CIAV/HD were obviously higher than that of PBS/CIAV/HD (P < 0.05) all the time. At 10 d post hatched, the CIAV viremia level was already very high; thus, we speculated that the vaccine might promote the assimilation of CIAV after oral vaccination; meanwhile, the CIAV viral load of group LaSota/CIAV/HD and group LaSota/CIAV/LD always kept a high level at 2 to 3 wk and then began to go down. Results about the group LaSota/CIAV/LD and group PBS/CIAV/LD were similar to the above ( Figure 4B ).
CIAV Significantly Decreases the NDV Antibody Titers
On 3, 4, 5, and 6 wk post-immunization with the attenuated vaccines, antibody titers to NDV in chickens from group LaSota/CIAV/HD and LaSota/CIAV/LD were significantly lower than that of the chickens from group LaSota (P < 0.05), respectively, which demonstrated that CIAV could seriously disturb the chicken immune response to NDV vaccine, and significantly reduce the NDV antibody titers and decrease the protective effectiveness. At the same time, the more CIAV contamination doses are, the higher decrease of NDV antibody titers shown in this experiment ( Figure 5 ).
LaSota Significantly Decreases the CIAV Antibody Titers
Sera from all chicks were collected at weeks 2, 3, 4, 5, and 6 of the experiment to determine the concentrations of CIAV antibody. Results showed that the CIAV antibody titers in LaSota/CIAV/HD were significantly lower than that of PBS/CIAV/LD (P < 0.05, Figure 6A ), which demonstrated that LaSota could disturb and decrease the growth of CIAV antibody. Results about the group LaSota/CIAV/LD and group PBS/CIAV/LD were similar to the above ( Figure 6B ).
DISCUSSION
Exogenous virus contamination in avian-attenuated vaccine is a unique source of infection for some contagious diseases. At present, most reports describing exogenous virus contamination mention ALV (Zavala and Cheng, 2006; Barbosa et al., 2008; Zhao et al., 2014) , REV (Fadly and Garcia, 2006; Awad et al., 2010; Wei et al., 2012; Li et al., 2015 Li et al., , 2016 , and CIAV (Yuasa et al., 1979; Marin et al., 2013; Varela et al., 2014; Li et al., 2017b) , which share the common feature of being able to propagate through the chick embryo. Among those vertically transmitted viruses, most attention was given to ALV or REV contamination in China rather than CIAV.
The CIAV contamination in NDV-attenuated vaccine was found from a chicken farm that had the typical CIA symptoms after using such vaccine (Li et al., 2017b) . However, it is difficult to detect CIAV in those positive samples by conventional PCR, demonstrating that the contamination dose was very low. Although the Figure 4 . Influence of different treatments on viremia levels of CIAV. Anticoagulant from all chicks was collected at different intervals of the experiment for DNA extraction to determine the viremia level of CIAV in high dose (HD) experiment (A) and low dose (LD) experiment (B), which was represented as Log copies/μL (mean value ± error). The CIAV viral load value of vaccination group was compared with that of the corresponding non-vaccination group ( * P < 0.05) based on Duncan's multiple-range test. Figure 5 . Influence of different treatments on the NDV antibody titers. Sera from all chicks were collected at different intervals of the experiment for hemagglutination inhibition testing to determine the concentrations of NDV antibody, which was represented as Log2 NDV antibody titer (mean value ± error). The NDV antibody value of noncontaminated group was compared with that of the corresponding contaminated group ( * P < 0.05) based on Duncan's multiple-range test.
interaction of CIAV and NDV-attenuated vaccine had been studied in the past (Box et al., 1988; De Boer et al., 1994; Lebdah et al., 2016) , it is still intriguing how the CIAV causes infection and then induces severe clinical symptoms in such low dose by oral infection, which was not an easy way for CIAV-infecting chickens even in a higher dose (van Santen et al., 2004) ; it is suspected that there must be a synergistic reaction between the LaSota strain and CIAV, which facilitates the oral infection of the CIAV. In this study, contaminated vaccine and corresponding virus PBS diluent were artificially prepared as trial samples using CIAV isolated from above-mentioned vaccine. Simulation experiments were then launched with those samples through the mouth to chickens. Surprisingly, the effects of LaSota on CIAV were enormous. Especially at the early period after vaccination, the existence of vaccine promoted the assimilation of CIAV, which might lay the foundations for the further multiplication of CIAV. Meanwhile, we conjectured that LaSota-with high adaptability and multiplication capacity in vivo-could occupy the major immune system and then decrease its response to CIAV, reducing the production of CIAV antibodies and lessening the inhibitory action on its multiplication. Furthermore, all of those would enhance the pathogenicity of CIAV and induce severe clinical or subclinical symptoms. Such synergistic reaction would aggravate the inhibitory action for weight growth of SPF chickens and enhance the capacity for one another to destroy the immune system.
On the other hand, as an exogenous contaminated virus, the effects of CIAV on LaSota were also infaust and obvious, significantly decreasing the NDV antibody titers, reducing its protective effectiveness, and ultimately providing more opportunities for wild NDV to attack those chickens with unqualified antibody levels. More importantly, CIAV elevated the viral load of NDV in many different organs, which is exactly what was hoped would not happen. Generally, despite LaSota potentially inducing systemic inflammation and respiratory symptoms (Niu et al., 2015) , the pathogenicity of LaSota was still too low to cause obvious damage to chickens. However, the pathogenicity of virus is opportunistic, which could sharply increase with the number rising. Therefore, the risk of such tremendous NDV viruses in vivo could not be ignored.
It is believed that CIAV and LaSota play separate but related roles in vivo, mutually improving pathogenicity under complex interactions. CIAV could damage the hemocytoblasts-the specialized progenitor cells from which the erythroid and myeloid series are derivedand reduce the erythrocyte, giving rise to anemia. Furthermore, the T lymphocyte progenitor cells in the thymus are also particularly susceptible to CIAV infection and appear to be a major target for the virus, causing atrophy of thymus glands and damage to the immune system (Adair, 2000) . On the other hand, excessive increments of LaSota will aggravate the systemic inflammation and respiratory symptoms, leading to the sickness worsening (Niu et al., 2015) . Meanwhile, the immune system was unable to produce enough antibodies to resist the multiplication of CIAV and LaSota under their synergistic reaction, providing opportunities for them to mass multiply and causing severe clinical symptoms.
In conclusion, this study observed the changes of NDV-attenuated vaccine LaSota under the contamination of exogenous virus, as well as the influences of Figure 6 . Influence of different treatments on the CIAV antibody titers. Sera from all chicks were collected at different intervals of the experiment to determine the concentrations of CIAV antibody in high dose (HD) experiment (A) and low dose (LD) experiment (B), which was represented as Log 10 CIAV antibody titer (mean value ± error). The CIAV antibody value of vaccination group was compared with that of the corresponding non-vaccination group ( * P < 0.05) based on Duncan's multiple-range test.
LaSota on CIAV in vivo. Doing so finally demonstrated that the interaction of CIAV and LaSota elevates the pathogenicity of one another, illustrating how the CIAV causes infection and induces severe diseases with a relatively low dose through the mouth. More importantly, this study reminds us to pay close attention to the copathogenicity of attenuated vaccine and contaminated exogenous virus within. Additionally, vaccine producers should guarantee that no exogenous virus is in their vaccines to avoid similar problems in the future.
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